Shuqin Yu

Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients

Libin Zhou, Guoyue Yuan, Hao Hu, 2014, Diabetes Care.

Reduced circulating oxytocin and High-Molecular-Weight adiponectin are risk factors for metabolic syndrome.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2016, Endocrine journal.

Circulating adiponectin levels and the risk of breast cancer: a meta-analysis

Chaoming Mao, Junjian Z. Chen, Jingjing Ye, 2014, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2014, Endocrine journal.

Association between retinol-binding protein 4 and polycystic ovary syndrome: a meta-analysis.

Guoyue Yuan, Ping Yang, Shuqin Yu, 2014, Endocrine journal.

Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial.

Libin Zhou, Dezhi Chen, Guoyue Yuan, 2015, Endocrine journal.

Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2014, The Journal of clinical endocrinology and metabolism.

Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2016, Endocrine journal.

Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls.

Libin Zhou, Chaoming Mao, Guoyue Yuan, 2016, Endocrine journal.